Business article - December 8, 2020
The Novo Nordisk Foundation establishes BioInnovation Institute as an independent foundation
The Novo Nordisk Foundation has announced that BioInnovation Institute (BII), a Novo Nordisk Foundation initiative, has been established as an independent foundation in recognition of its success incubating and accelerating world-class life science research. BII was established in December 2017 by the Novo Nordisk Foundation with the purpose to advance research, innovation and entrepreneurship within […]
Business article - October 10, 2020
BII awards 14 million EUR to startups and research projects
Novo Nordisk Foundation’s innovation initiative, BioInnovation Institute (BII) has awarded EUR 14 million to eight early-stage life science start-ups and research projects. BII has accepted five early-stage start-up companies into the Creation House life science incubator program with EUR 1.3 million in funding for each start-up company. Among the new life science innovations that have […]
Science article - June 20, 2020
How to succeed with heterologous genes
Scientists at the Technical University of Denmark upend conventional wisdom about introducing new genes into bacteria. Why do some foreign genes work well in a new host and some do not? The reasons are critical for synthetic biologists who add heterologous genes to bacteria. The issue is clinically relevant, since bacteria gain antibiotic resistance through […]
Collaboration - June 11, 2020
Nordic initiative offers courses in health innovation
The School of Health Innovation, founded by Karolinska Institutet, KI, Oslo University, UiO, and Norwegian University of Science and Technology NTNU, is the first Nordic initiative to offer courses in innovation as an extension of the academic subjects health sciences and life sciences. In addition, the University of Copenhagen will be joining the initiative shortly […]
Uncategorized - June 3, 2020
Novo Nordisk leads international obesity project
Novo Nordisk leads the international, public-private research consortium ‘SOPHIA’ (Stratification of Obese Phenotypes to Optimize Future Obesity Therapy), which was launched with the aim of improving risk assessment of comorbidities and treatment for people with obesity. Twenty-nine leading international partners from civil society, academia and industry have joined forces to better understand obesity and optimize […]
In a new job - April 20, 2020
Medicon Valley Alliance strengthens its Board of Directors
The Board of Directors of Medicon Valley Alliance (MVA), the Danish-Swedish life science cluster organization, have welcomed new members. At the Ordinary General Meeting, Thursday 16th of April, which was organized as an online meeting, the MVA Board of Directors welcomed Linn Mandahl, General Manager at AbbVie Scandinavia, as a new board member. “It is […]
